Worldwide, cardiovascular diseases claim a number of lives; however, some
of them are preventable with an early and proper management. Still, the treatment of
cardiovascular diseases is limited as it deals with prescribed medicines administered
orally and under critical condition with invasive surgery. Due to this, there exists an
enormous gap in the area of medicine for the development of therapies for better
patient outcomes. In this regard, recently, nanotechnological aspects of the
development of medicines are sought, which may provide a solution for more effective
treatment of disease, having better therapeutic outcomes with reduced side effect
profile. Further, the regenerative nanomedicine therapeutic approach opens up a
paradigm that deals with the repair of damaged heart tissue and future potential use of
such systems.
Keywords: Bioavailability, Cardiomyocytes, Nanomaterials, Nanomedicine,
Nanoscience.